Skip to main content
padlock icon - secure page this page is secure

Allergenicity of recombinant human lactoferrin to an animal model Brown Norway rats

Buy Article:

$63.00 + tax (Refund Policy)

The assessment of allergenicity of recombinant human lactoferrin (rhLF) using an animal model for its extensive use. In this study, 32 Brown Norway (BN) rats were divided into four groups that were exposed to ovalbumin (OVA) (positive control), rhLF, bovine lactoferrin (bLF) and saline (negative control), respectively, with daily intragastric administration for 42 days. The level of specific antibody (IgE, IgG and IgG2a), blood cell counts, blood pressure and pathology of important organs were measured and compared among the groups. OVA stimulated significant higher levels of specific-IgE and eosinophil (EO) counts (p <0.05), lower blood pressure (p<0.05) and more serious lesion in the lung of BN rats compared to the other groups. And the animals did not show obvious humeral, cell-mediated and local allergic response to rhLF and bLF. The results demonstrate a weak allergenicity of rhLF on the animal and reveal its potential value for further identified study.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: BN rat; allergenicity; recombinant human lactoferrin

Document Type: Research Article

Affiliations: 1: College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China 2: Institute of Zoology, Chinese Academy of Sciences, Beijing, P. R. China 3: Department of Dermatology, the First Affiliated Hospital of Herbin Medical University, Harbin, China 4: Institute for Food Safety and Health, U.S. Food and Drug Administration and Illinois institute of Technology, Summi-Argo, IL, USA

Publication date: January 2, 2014

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more